{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T19:01:06Z","timestamp":1780426866718,"version":"3.54.1"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"39","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,26]]},"abstract":"<jats:p>\n                    Meningiomas are prevalent central nervous system tumors with unclear etiological mechanisms. Due to their location outside the blood\u2013brain barrier, they may be susceptible to systemic inflammatory responses. This study aimed to explore the causal relationship between 91 inflammatory proteins and meningiomas through 2-sample Mendelian randomization (MR). Using genome-wide association studies data from 14,824 participants, single nucleotide polymorphisms associated with inflammatory proteins were selected as instrumental variables. Meningioma data were obtained from a Finnish database (1316 cases and 3,13,392 controls). The inverse-variance weighted method assessed associations, with sensitivity analyses to ensure robustness. Reverse MR examined meningioma impact on inflammatory proteins. Forward MR analysis showed elevated Fms-related tyrosine kinase 3 ligand (FLT3L) levels correlated with reduced meningioma risk (OR\u2005=\u20050.72, 95% CI\u2005=\u20050.61\u20130.85,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001). Reverse MR suggested meningiomas might lower plasma FLT3L, C-X-C motif chemokine 11, adenosine deaminase, and hepatocyte growth factor levels. FLT3L may play a protective role in meningiomas, warranting further research on inflammatory proteins for prevention and treatment strategies.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000044477","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:03:38Z","timestamp":1759248218000},"page":"e44477","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Two-sample Mendelian randomization analysis of 91 circulating inflammatory protein levels and meningioma"],"prefix":"10.1097","volume":"104","author":[{"given":"Jiewen","family":"Xin","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Hui\u2019an County Hospital and Hui\u2019an County Hospital Affiliated to Quanzhou Medical College, Quanzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiangbin","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Second Affiliated Hospital of Fujian Medical, Quanzhou, Fujian Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianyong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hui\u2019an County Hospital and Hui\u2019an County Hospital Affiliated to Quanzhou Medical College, Quanzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peikun","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hui\u2019an County Hospital and Hui\u2019an County Hospital Affiliated to Quanzhou Medical College, Quanzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2595-9050","authenticated-orcid":false,"given":"Weipeng","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Second Affiliated Hospital of Fujian Medical, Quanzhou, Fujian Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9084-9451","authenticated-orcid":false,"given":"Zhenyong","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hui\u2019an County Hospital and Hui\u2019an County Hospital Affiliated to Quanzhou Medical College, Quanzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260602","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(04)16153-9","article-title":"Meningiomas.","volume":"363","author":"Whittle","year":"2004","journal-title":"Lancet"},{"key":"R2-20260602","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s13244-013-0302-4","article-title":"Magnetic resonance imaging of meningiomas: a pictorial review.","volume":"5","author":"Watts","year":"2014","journal-title":"Insights Imaging"},{"issue":"suppl_5","key":"R3-20260602","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/neuonc\/nox158","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014.","volume":"19","author":"Ostrom","year":"2017","journal-title":"Neuro Oncol"},{"key":"R4-20260602","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11060-010-0386-3","article-title":"Epidemiology and etiology of meningioma.","volume":"99","author":"Wiemels","year":"2010","journal-title":"J Neurooncol"},{"key":"R5-20260602","doi-asserted-by":"crossref","first-page":"e13048","DOI":"10.1111\/bpa.13048","article-title":"Molecular neuropathology of brain-invasive meningiomas.","volume":"32","author":"von Spreckelsen","year":"2022","journal-title":"Brain Pathol"},{"key":"R6-20260602","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/ni.3790","article-title":"A guiding map for inflammation.","volume":"18","author":"Netea","year":"2017","journal-title":"Nat Immunol"},{"key":"R7-20260602","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.3390\/ph16091242","article-title":"Inflammation in coronary atherosclerosis: insights into pathogenesis and therapeutic potential of anti-inflammatory drugs.","volume":"16","author":"Figueiredo","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"R8-20260602","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer.","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"R9-20260602","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1158\/1078-0432.CCR-22-1031","article-title":"Cancer-associated fibroblasts in inflammation and antitumor immunity.","volume":"29","author":"Kennel","year":"2023","journal-title":"Clin Cancer Res"},{"key":"R10-20260602","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12199-018-0740-1","article-title":"Inflammation and cancer.","volume":"23","author":"Murata","year":"2018","journal-title":"Environ Health Preventative Med"},{"key":"R11-20260602","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ije\/dyg070","article-title":"\u201cMendelian randomization\u201d: can genetic epidemiology contribute to understanding environmental determinants of disease?","volume":"32","author":"Smith","year":"2003","journal-title":"Int J Epidemiol"},{"key":"R12-20260602","doi-asserted-by":"crossref","first-page":"k601","DOI":"10.1136\/bmj.k601","article-title":"Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians.","volume":"362","author":"Davies","year":"2018","journal-title":"BMJ"},{"key":"R13-20260602","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/s41590-023-01588-w","article-title":"Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets.","volume":"24","author":"Zhao","year":"2023","journal-title":"Nat Immunol"},{"key":"R14-20260602","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1182\/blood.V91.4.1101","article-title":"c-kit ligand and Flt3 ligand: stem\/progenitor cell factors with overlapping yet distinct activities.","volume":"91","author":"Lyman","year":"1998","journal-title":"Blood"},{"key":"R15-20260602","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev-immunol-020711-074950","article-title":"The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting.","volume":"31","author":"Merad","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"R16-20260602","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00281-016-0602-0","article-title":"The origin of DCs and capacity for immunologic tolerance in central and peripheral tissues.","volume":"39","author":"Devi","year":"2017","journal-title":"Semin Immunopathol"},{"key":"R17-20260602","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1189\/jlb.0307166","article-title":"Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T-cells, and effector T-cells.","volume":"82","author":"Cools","year":"2007","journal-title":"J Leukoc Biol"},{"key":"R18-20260602","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nature06175","article-title":"Taking dendritic cells into medicine.","volume":"449","author":"Steinman","year":"2007","journal-title":"Nature"},{"key":"R19-20260602","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/978-3-030-59038-3_3","article-title":"Meningioma tumor microenvironment.","volume":"1296","author":"Sahab-Negah","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"R20-20260602","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1084\/jem.20102657","article-title":"Flt3L controls the development of radiosensitive dendritic cells in the meninges and choroid plexus of the steady-state mouse brain.","volume":"208","author":"Anandasabapathy","year":"2011","journal-title":"J Exp Med"},{"key":"R21-20260602","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1158\/2326-6066.CIR-22-0098","article-title":"The conventional dendritic cell 1 subset primes CD8+ T-cells and traffics tumor antigen to drive antitumor immunity in the brain.","volume":"11","author":"Bowman-Kirigin","year":"2023","journal-title":"Cancer Immunol Res"},{"key":"R22-20260602","doi-asserted-by":"crossref","first-page":"1755214","DOI":"10.1080\/2162402X.2020.1755214","article-title":"FLT3LG - a biomarker reflecting clinical responses to the immunogenic cell death inducer oxaliplatin.","volume":"9","author":"Pol","year":"2020","journal-title":"Oncoimmunology"},{"key":"R23-20260602","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1084\/jem.187.12.2009","article-title":"Interferon-inducible T-cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T-cells through selective high affinity binding to CXCR3.","volume":"187","author":"Cole","year":"1998","journal-title":"J Exp Med"},{"key":"R24-20260602","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/10732748241241162","article-title":"The role of CXCL11 and its receptors in cancer: prospective but challenging clinical targets.","volume":"31","author":"Wang","year":"2024","journal-title":"Cancer Control"},{"key":"R25-20260602","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1093\/neuonc\/noad076","article-title":"Stem-like signatures in human meningioma cells are under the control of CXCL11\/CXCL12 chemokine activity.","volume":"25","author":"Barbieri","year":"2023","journal-title":"Neuro Oncol"},{"key":"R26-20260602","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/nature01320","article-title":"Points of control in inflammation.","volume":"420","author":"Nathan","year":"2002","journal-title":"Nature"},{"key":"R27-20260602","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF01809267","article-title":"Serum adenosine deaminase activity in brain tumours.","volume":"121","author":"Manjula","year":"1993","journal-title":"Acta Neurochir (Wien)"},{"key":"R28-20260602","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.ijbiomac.2019.09.078","article-title":"Adenosine deaminase inhibition.","volume":"141","author":"Bagheri","year":"2019","journal-title":"Int J Biol Macromol"},{"key":"R29-20260602","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.autrev.2014.11.013","article-title":"Hepatocyte growth factor: a regulator of inflammation and autoimmunity.","volume":"14","author":"Molnarfi","year":"2015","journal-title":"Autoimmun Rev"},{"key":"R30-20260602","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.biocel.2011.04.006","article-title":"Hepatocyte growth factor-induced c-Src-phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin pathway inhibits dendritic cell activation by blocking I\u03baB kinase activity.","volume":"43","author":"Singhal","year":"2011","journal-title":"Int J Biochem Cell Biol"},{"key":"R31-20260602","doi-asserted-by":"crossref","first-page":"32054","DOI":"10.1074\/jbc.M111.271247","article-title":"A novel role for Bruton\u2019s tyrosine kinase in hepatocyte growth factor-mediated immunoregulation of dendritic cells.","volume":"286","author":"Singhal","year":"2011","journal-title":"J Biol Chem"},{"key":"R32-20260602","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.4049\/jimmunol.1200729","article-title":"The HGF receptor\/met tyrosine kinase is a key regulator of dendritic cell migration in skin immunity.","volume":"189","author":"Baek","year":"2012","journal-title":"J Immunol"},{"key":"R33-20260602","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.4049\/jimmunol.175.7.4745","article-title":"A novel role of hepatocyte growth factor as an immune regulator through suppressing dendritic cell function.","volume":"175","author":"Okunishi","year":"2005","journal-title":"J Immunol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044477","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T18:02:37Z","timestamp":1780423357000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":33,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044477","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"2025-05-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}